NEKTAR THERAPEUTICS's ticker is NKTR and the CUSIP is 640268108. A total of 199 filers reported holding NEKTAR THERAPEUTICS in Q4 2016. The put-call ratio across all filers is 0.63 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2021 | $905,000 | -24.6% | 67,000 | 0.0% | 0.20% | -30.3% |
| Q3 2021 | $1,201,000 | +4.5% | 67,000 | 0.0% | 0.29% | -4.3% |
| Q2 2021 | $1,149,000 | -14.3% | 67,000 | 0.0% | 0.30% | -14.4% |
| Q1 2021 | $1,340,000 | +17.6% | 67,000 | 0.0% | 0.35% | +13.8% |
| Q4 2020 | $1,139,000 | +2.6% | 67,000 | 0.0% | 0.31% | -13.1% |
| Q3 2020 | $1,110,000 | -26.0% | 67,000 | 0.0% | 0.36% | -28.1% |
| Q2 2020 | $1,499,000 | +25.6% | 67,000 | 0.0% | 0.50% | -8.5% |
| Q1 2020 | $1,193,000 | -60.5% | 67,000 | -52.1% | 0.54% | -50.0% |
| Q4 2019 | $3,021,000 | +176.4% | 140,000 | +133.3% | 1.09% | +115.4% |
| Q3 2019 | $1,093,000 | -48.8% | 60,000 | 0.0% | 0.50% | -36.2% |
| Q2 2019 | $2,135,000 | +5.9% | 60,000 | 0.0% | 0.79% | +6.3% |
| Q1 2019 | $2,016,000 | +30.2% | 60,000 | 0.0% | 0.74% | -22.5% |
| Q4 2018 | $1,548,000 | -87.7% | 60,000 | -71.6% | 0.96% | -78.4% |
| Q4 2017 | $12,597,000 | +794.7% | 211,000 | +251.7% | 4.44% | +723.9% |
| Q1 2017 | $1,408,000 | +91.3% | 60,000 | 0.0% | 0.54% | +62.3% |
| Q4 2016 | $736,000 | – | 60,000 | – | 0.33% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Camber Capital Management LP | 2,000,000 | $67,200,000 | 3.35% |
| First Light Asset Management, LLC | 763,403 | $25,650,000 | 3.33% |
| BRIDGER MANAGEMENT, LLC | 1,238,489 | $41,613,000 | 3.29% |
| Rhenman & Partners Asset Management AB | 734,445 | $24,677,000 | 2.89% |
| BB BIOTECH AG | 2,020,676 | $67,895,000 | 1.71% |
| Gs Investments, Inc. | 54,200 | $1,821,120,000 | 1.43% |
| Artal Group S.A. | 900,000 | $30,240,000 | 1.24% |
| Cormorant Asset Management, LP | 500,000 | $16,800,000 | 1.14% |
| TOBAM | 640,547 | $21,522,000 | 1.09% |
| Bellevue Group AG | 430,026 | $14,449,000 | 0.80% |